Glaucoma Eye Care
Board
1 director, since incorporationDirector (not named in the articles)
since 20-12-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 20-03-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 22-12-2023
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), from 20-12-2023 to date
Control
Founder
This company
Glaucoma Eye Care
Equity €271,853
Profit €211,089 in 2025
Capital
- Contribution
- €2,500
- Shares
- 120
- Contribution per share
- €20.83
- Equity per share
- €2,265 in 2025
- Source
- deed of 22-12-2023
Articles of association
deed of 22-12-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- Geheel of gedeeltelijk herroepbaar om gewichtige redenen bij besluit algemene vergadering met vereisten statutenwijziging, één of meer bestuurders,artsen-aandee…Onbezoldigd tenzij anders beslist door algemene vergadering, werkverdeling,alle vergoedingen inclusief bezoldiging bestuurder en terugbetalingen kosten en vacat…
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- Voor overdracht medische dossiers bijgestaan door arts, een of meerdere vereffenaars aanduiden,bevoegdheden omlijnen,vergoeding bepalen
Shareholders
At incorporation
deed of 22-12-2023 ↗
- 120 shares (100%) · €2,500